The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Trident Texofab Ltd & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Texofab Limited along with Persons Acting in Concert (PACs), which are part of the promoter group, have disclosed an acquisition of 30,010 convertible equity warrants in Trident Lifeline Limited under a preferential offer on June 9, 2025. As per the filing under SEBI SAST Regulation 29(2), the promoter group's aggregate holding increased to 72,49,400 shares, representing 63.04% of the expanded share capital (post preferential allotment total of 1,24,93,400 equity shares). Before the acquisition, the promoter group held 59,34,000 shares on a pre-allotment capital of 1,14,99,200 equity shares. The preferential allotment also increased the total outstanding equity share base of Trident Lifeline Limited.
This signals promoter confidence and strengthening of promoter control in Trident Lifeline, raising the promoter holding from ~51.6% to 63.04%. For retail shareholders, it means higher promoter commitment but also reduced free float, which may improve governance stability while potentially lowering liquidity in the stock.